20.01.2010 21:05:00
|
Phase Forward to Present at the Jefferies 2010 Global Healthcare Services Conference
Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its senior vice president and chief financial officer, Chris Menard, and senior vice president of products and services, Steve Rosenberg, will present at the Jefferies 2010 Global Healthcare Services Conference at the Mandarin Oriental Hotel in New York City.
The Phase Forward presentation is scheduled for Wednesday, January 27, 2010 at 11:15 a.m. ET. The presentation will be webcast live and will be available by visiting the Investors section of the company’s website at www.phaseforward.com. The webcast will be archived on the company’s website for 30 days after the conference ends.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Oracle Corp.mehr Nachrichten
19.11.24 |
NASDAQ Composite Index-Wert Oracle-Aktie: So viel hätten Anleger an einem Oracle-Investment von vor einem Jahr verdient (finanzen.at) | |
15.11.24 |
NASDAQ Composite Index-Papier Oracle-Aktie: Über diese Dividendenzahlung können sich Oracle-Aktionäre freuen (finanzen.at) | |
14.11.24 |
Donnerstagshandel in New York: NASDAQ Composite fällt schlussendlich (finanzen.at) | |
14.11.24 |
Handel in New York: NASDAQ Composite präsentiert sich schwächer (finanzen.at) | |
14.11.24 |
Donnerstagshandel in New York: NASDAQ Composite am Donnerstagmittag mit Abgaben (finanzen.at) | |
14.11.24 |
Minuszeichen in New York: NASDAQ Composite zum Start des Donnerstagshandels in Rot (finanzen.at) | |
13.11.24 |
Börse New York in Rot: NASDAQ Composite letztendlich schwächer (finanzen.at) | |
13.11.24 |
Freundlicher Handel in New York: NASDAQ Composite klettert am Nachmittag (finanzen.at) |
Analysen zu Oracle Corp.mehr Analysen
23.10.24 | Oracle Sector Perform | RBC Capital Markets | |
07.10.24 | Oracle Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.09.24 | Oracle Kaufen | DZ BANK | |
25.09.24 | Oracle Buy | UBS AG | |
16.09.24 | Oracle Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Oracle Corp. | 173,06 | 0,07% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 060,48 | -0,60% |